1164 Purpose: Bone scintigraphy with Tc-99m-labeled diphosphonate can identify fibrous
dysplasia (FD), which typically exhibits markedly increased tracer uptake. The aim of this …

Purpose To investigate the emerging role of Tc-99m-labeled diphosphonate (Tc-99m-DPD)
uptake quantification by SPECT/CT in fibrous dysplasia (FD) bone lesions and its correlation …

Background Fibrous dysplasia (FD) is a rare benign bone disorder in which the normal bone
is replaced by immature fibro-osseous tissue. However, some case reports have reported …

Purpose: To investigate the emerging role of Tc-99m-labeled diphosphonate (Tc-99m-DPD)
uptake quantification by SPECT/CT in fibrous dysplasia (FD) bone lesions and its correlation …

Abstract Purpose To quantify Na 18 F-PET/CT uptake in relation to clinical and biochemical
parameters of fibrous dysplasia (FD) severity and healthy bone (HB) metabolism. Secondary …

Purpose The aim of this study was to determine the role of whole-body Tc-99m MDP bone
scintigraphy (BSc) with dual-phase Tc-99m MIBI scintigraphy (DPMSc) in the assessment of …

Dear Sir, We would like to respond to the interesting Letter to the Editor by colleagues
Duarte and Sapienza [1], commenting on our recent original article [2]. To start, we would …

90 Objectives: Fibrous dysplasia (FD) is a benign skeletal disorder characterized by the
replacement of normal bone and normal bone marrow with abnormal fibro-osseous tissue …

Fibrous dysplasia (FD) is a mosaic skeletal disorder resulting in fractures, deformity, and
functional impairment. Clinical evaluation has been limited by a lack of surrogate endpoints …

Purpose: The purpose of this study was to study the characteristics of fibrous dysplasia (FD)
of bone on bone scans and to evaluate the diagnostic value of radionuclide bone scans in …